Big Phar­ma PACs blan­ket the elec­tion field with mil­lions in con­tri­bu­tions ahead of midterms

Phar­ma com­pa­nies may be up in arms with De­moc­rats over their re­cent­ly passed leg­is­la­tion to al­low Medicare to ne­go­ti­ate cer­tain ex­pen­sive drug prices, but their po­lit­i­cal ac­tion com­mit­tees (PACs) aren’t show­ing it, with con­tri­bu­tions for both De­moc­rats and Re­pub­li­cans across the coun­try.

Ac­cord­ing to Fed­er­al Elec­tion Com­mis­sion’s cam­paign fi­nance data­base, the PACs for Pfiz­er, John­son & John­son, Sanofi, Mer­ck, No­var­tis, Ab­b­Vie, Bris­tol My­ers Squibb and Eli Lil­ly con­tributed more than $7 mil­lion to na­tion­al and state po­lit­i­cal cam­paigns last year and so far this year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.